V. Hirsch, Vpx is required for dissemination and pathogenesis of SIVSM PBj: Evidence of macrophage-dependent viral amplification, Nature Medicine, vol.14, issue.12, pp.1401-1408, 1998.
DOI : 10.1038/345636a0

C. Verhofstede, M. Nijhuis, and L. Vandekerckhove, Correlation of coreceptor usage and disease progression, Current Opinion in HIV and AIDS, vol.7, issue.5, pp.432-439, 2012.
DOI : 10.1097/COH.0b013e328356f6f2

A. Brass, Identification of Host Proteins Required for HIV Infection Through a Functional Genomic Screen, Science, vol.317, issue.5840, pp.921-926, 2008.
DOI : 10.1126/science.1143767

R. Konig, Global Analysis of Host-Pathogen Interactions that Regulate Early-Stage HIV-1 Replication, Cell, vol.135, issue.1, pp.49-60, 2008.
DOI : 10.1016/j.cell.2008.07.032

N. Yan and Z. Chen, Intrinsic antiviral immunity, Nature Immunology, vol.66, issue.3, pp.214-222, 2012.
DOI : 10.1038/nature06042
URL : http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3549670

O. Lambotte, HIV Controllers: A Homogeneous Group of HIV-1--Infected Patients with Spontaneous Control of Viral Replication, Clinical Infectious Diseases, vol.41, issue.7, pp.1053-1056, 2005.
DOI : 10.1086/433188

S. Migueles, HLA B*5701 is highly associated with restriction of virus replication in a subgroup of HIV-infected long term nonprogressors, Proceedings of the National Academy of Sciences, vol.375, issue.6532, pp.2709-2714, 2000.
DOI : 10.1038/375606a0

J. Okulicz, Clinical outcomes of elite controllers, viremic controllers, and long?term 10 nonprogressors in the US Department of Defense HIV natural history study, J Infect, vol.11

F. Pereyra, Genetic and immunologic heterogeneity among persons who control HIV 13 infection in the absence of therapy HIV controllers: how do they tame 15 the virus? Trends Immunol, J Infect Dis, vol.19728, issue.16, pp.532-540, 2007.

Y. Madec, F. Boufassa, K. Porter, and L. Meyer, Spontaneous control of viral load and CD4 cell count 17 progression among HIV?1 seroconverters, AIDS, vol.19, issue.18, p.13, 2005.

F. Boufassa, CD4 Dynamics over a 15 Year-Period among HIV Controllers Enrolled in the ANRS French Observatory, PLoS ONE, vol.4, issue.9, pp.18726-18740, 2011.
DOI : 10.1371/journal.pone.0018726.t002
URL : https://hal.archives-ouvertes.fr/pasteur-01420582

S. Grabar, H. Selinger?leneman, S. Abgrall, G. Pialoux, L. Weiss et al., Prevalence and 21 comparative characteristics of long?term nonprogressors and HIV controller patients in the French 22 Hospital Database on HIV Definition, Natural History and Heterogeneity of HIV 24 controllers, Models of Protection Against HIV/SIV Avoiding 25 AIDS in humans and monkeys, pp.233-252, 2009.

C. Goujard, Spontaneous Control of Viral Replication during Primary HIV Infection: When Is ???HIV Controller??? Status Established?, Clinical Infectious Diseases, vol.49, issue.6, pp.982-986, 2009.
DOI : 10.1086/605504

A. Kim, Spontaneous Control of HCV Is Associated With Expression of HLA-B*57 and Preservation of Targeted Epitopes, Gastroenterology, vol.140, issue.2, pp.686-696, 2011.
DOI : 10.1053/j.gastro.2010.09.042

E. Ruiz?mateos, Hepatitis C virus replication in Caucasian HIV controllers. J Viral 31 Hepat, pp.350-357, 2011.

H. Hatano, Evidence for Persistent Low-Level Viremia in Individuals Who Control Human Immunodeficiency Virus in the Absence of Antiretroviral Therapy, Journal of Virology, vol.83, issue.1, pp.329-335, 2009.
DOI : 10.1128/JVI.01763-08

H. Mens, HIV-1 Continues To Replicate and Evolve in Patients with Natural Control of HIV Infection, Journal of Virology, vol.84, issue.24, pp.12971-12981, 2010.
DOI : 10.1128/JVI.00387-10

F. Pereyra, Persistent Low???Level Viremia in HIV???1 Elite Controllers and Relationship to Immunologic Parameters, The Journal of Infectious Diseases, vol.200, issue.6, pp.984-990, 2009.
DOI : 10.1086/605446

V. Dahl, Single?copy assay quantification of HIV?1 RNA in paired cerebrospinal fluid and 39 plasma samples from elite controllers, AIDS, vol.40, p.23, 2012.

J. Probasco, Cerebrospinal fluid in HIV-1 systemic viral controllers: absence of HIV-1 RNA and intrathecal inflammation, AIDS, vol.24, issue.7, pp.1001-1005, 2010.
DOI : 10.1097/QAD.0b013e328331e15b

P. Hunt, Relationship between T cell activation and CD4+ T cell count in HIV? 43 seropositive individuals with undetectable plasma HIV RNA levels in the absence of therapy, J Infect, p.44

F. Vigneault, Transcriptional Profiling of CD4 T Cells Identifies Distinct Subgroups of HIV-1 Elite Controllers, Journal of Virology, vol.85, issue.6, pp.3015-3019, 2011.
DOI : 10.1128/JVI.01846-10

J. Okulicz, CD4 T Cell Count Reconstitution in HIV Controllers after Highly Active Antiretroviral Therapy, Clinical Infectious Diseases, vol.50, issue.8, pp.1187-1191, 2010.
DOI : 10.1086/651421

A. Sedaghat, D. Rastegar, O. Connell, K. Dinoso, J. Wilke et al., T cell dynamics 50 and the response to HAART in a cohort of HIV?1?infected elite suppressors, Clin Infect, p.51

J. Brenchley, Microbial translocation is a cause of systemic immune activation in chronic HIV infection, Nature Medicine, vol.174, issue.12, pp.1365-1371, 2006.
DOI : 10.1038/nm1511

S. Potter, Preserved Central Memory and Activated Effector Memory CD4+ T-Cell Subsets in Human Immunodeficiency Virus Controllers: an ANRS EP36 Study, Journal of Virology, vol.81, issue.24, pp.13904-13915, 2007.
DOI : 10.1128/JVI.01401-07
URL : https://hal.archives-ouvertes.fr/pasteur-00193768

Y. Yang, CD4 T-cell regeneration in HIV-1 elite controllers, AIDS, vol.26, issue.6, pp.701-706, 2012.
DOI : 10.1097/QAD.0b013e3283519b22
URL : http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3729591

D. Sauce, HIV disease progression despite suppression of viral replication is associated with exhaustion of lymphopoiesis, Blood, vol.117, issue.19, pp.5142-5151, 2011.
DOI : 10.1182/blood-2011-01-331306

J. Bailey, T. Williams, R. Siliciano, and J. Blankson, elite suppressors despite CTL escape mutations, The Journal of Experimental Medicine, vol.69, issue.5, pp.1357-1369, 2006.
DOI : 10.1089/08892220260235425
URL : http://www.ncbi.nlm.nih.gov/pmc/articles/PMC2121215

J. Dinoso, S. Kim, R. Siliciano, and J. Blankson, A comparison of viral loads between HIV?1? 10 infected elite suppressors and individuals who receive suppressive highly active antiretroviral 11 therapy, Clin Infect Dis, vol.47, issue.12, p.34, 2008.

J. Blankson, Isolation and Characterization of Replication?Competent HIV?1 from a 13 Subset of Elite Suppressors, J Virol, vol.81, issue.14, p.35, 2007.

S. Lewin and C. Rouzioux, HIV cure and eradication: how will we get from the laboratory to effective clinical trials?, AIDS, vol.25, issue.7, pp.885-897, 2011.
DOI : 10.1097/QAD.0b013e3283467041

O. Connell, K. Brennan, T. Bailey, J. Ray, S. Siliciano et al., Control of HIV-1 in Elite Suppressors despite Ongoing Replication and Evolution in Plasma Virus, Journal of Virology, vol.84, issue.14, pp.7018-7028, 2010.
DOI : 10.1128/JVI.00548-10

M. Salgado, Evolution of the HIV?1 nef gene in HLA?B*57 positive elite suppressors Escape from the dominant HLA?B27?restricted cytotoxic T?lymphocyte 21 response in Gag is associated with a dramatic reduction in human immunodeficiency virus type 1 22 replication, Retrovirology. J Virol, vol.781, issue.23, pp.12382-12393, 2007.

M. Brockman, Escape and Compensation from Early HLA-B57-Mediated Cytotoxic T-Lymphocyte Pressure on Human Immunodeficiency Virus Type 1 Gag Alter Capsid Interactions with Cyclophilin A, Journal of Virology, vol.81, issue.22, pp.12608-12618, 2007.
DOI : 10.1128/JVI.01369-07

T. Miura, HLA-B57/B*5801 Human Immunodeficiency Virus Type 1 Elite Controllers Select for Rare Gag Variants Associated with Reduced Viral Replication Capacity and Strong Cytotoxic T-Lymphotye Recognition, Journal of Virology, vol.83, issue.6, pp.2743-2755, 2009.
DOI : 10.1128/JVI.02265-08

J. Martinez?picado, Fitness Cost of Escape Mutations in p24 Gag in Association with Control of Human Immunodeficiency Virus Type 1, Journal of Virology, vol.80, issue.7, pp.3617-3623, 2006.
DOI : 10.1128/JVI.80.7.3617-3623.2006

T. Miura, HLA-Associated Alterations in Replication Capacity of Chimeric NL4-3 Viruses Carrying gag-protease from Elite Controllers of Human Immunodeficiency Virus Type 1, Journal of Virology, vol.83, issue.1, pp.140-149, 2009.
DOI : 10.1128/JVI.01471-08

K. Lassen, Elite Suppressor???Derived HIV-1 Envelope Glycoproteins Exhibit Reduced Entry Efficiency and Kinetics, PLoS Pathogens, vol.3, issue.4, pp.1000377-1000413, 2009.
DOI : 10.1371/journal.ppat.1000377.s004
URL : http://doi.org/10.1371/journal.ppat.1000377

Z. Brumme, Reduced replication capacity of NL4?3 recombinant viruses encoding 37 reverse transcriptase?integrase sequences from HIV?1 elite controllers. J Acquir Immune Defic 38 Syndr, pp.100-108, 2011.

P. Mwimanzi, Attenuation of multiple Nef functions in HIV-1 elite controllers, Retrovirology, vol.10, issue.1, pp.1-41, 2012.
DOI : 10.1073/pnas.1530509100

T. Miura, Genetic Characterization of Human Immunodeficiency Virus Type 1 in Elite Controllers: Lack of Gross Genetic Defects or Common Amino Acid Changes, Journal of Virology, vol.82, issue.17, pp.8422-8430, 2008.
DOI : 10.1128/JVI.00535-08

T. Miura, Impaired Replication Capacity of Acute/Early Viruses in Persons Who Become HIV Controllers, Journal of Virology, vol.84, issue.15, pp.7581-7591, 2010.
DOI : 10.1128/JVI.00286-10

A. Lamine, Replication?competent HIV strains infect HIV controllers despite 46 undetectable viremia (ANRS EP36 study) Saez?Cirion A, et al. Heterogeneity in HIV suppression by CD8 T cells from HIV controllers: 48 association with Gag?specific CD8 T cell responses, Aids. J Immunol, vol.21182, issue.49, pp.1043-1045, 2007.

B. Julg, T Cells in HIV Elite Controllers, Clinical Infectious Diseases, vol.51, issue.2, pp.233-238, 2010.
DOI : 10.1086/653677

R. Buckheit, Host factors dictate control of viral replication in two HIV-1 controller/chronic progressor transmission pairs, Nature Communications, vol.78, issue.2, pp.716-52, 2012.
DOI : 10.1038/ncomms1697

M. Navis, Viral Replication Capacity as a Correlate of HLA B57/B5801-Associated Nonprogressive HIV-1 Infection, The Journal of Immunology, vol.179, issue.5, pp.3133-3143, 2007.
DOI : 10.4049/jimmunol.179.5.3133

J. Bailey, Transmission of Human Immunodeficiency Virus Type 1 from a Patient Who Developed AIDS to an Elite Suppressor, Journal of Virology, vol.82, issue.15, pp.7395-7410, 2008.
DOI : 10.1128/JVI.00800-08

J. Fellay, A Whole-Genome Association Study of Major Determinants for Host Control of HIV-1, Science, vol.108, issue.10, pp.944-947, 2007.
DOI : 10.1182/blood-2006-06-030668

S. Limou, Genes (ANRS Genomewide Association Study 02), The Journal of Infectious Diseases, vol.199, issue.3, pp.419-429, 2009.
DOI : 10.1086/596067

R. Kaslow, Influence of combinations of human major histocompatibility complex genes on the course of HIV???1 infection, Nature Medicine, vol.148, issue.4, pp.405-411, 1996.
DOI : 10.1016/0198-8859(94)90041-8

K. Pelak, Host Determinants of HIV???1 Control in African Americans, The Journal of Infectious Diseases, vol.201, issue.8
DOI : 10.1086/651382

P. Mclaren, Fine-mapping classical HLA variation associated with durable host control of HIV-1 infection in African Americans, Human Molecular Genetics, vol.21, issue.19, pp.4334-4347, 2012.
DOI : 10.1093/hmg/dds226

F. Pereyra, The major genetic determinants of HIV?1 control affect HLA class I peptide 18 presentation, Science, vol.330, issue.19, pp.1551-1557, 2010.

R. Thomas, HLA-C cell surface expression and control of HIV/AIDS correlate with a variant upstream of HLA-C, Nature Genetics, vol.24, issue.12, pp.1290-1294, 2009.
DOI : 10.1038/ng.486

S. Kulkarni, Differential microRNA regulation of HLA-C expression and its association with HIV control, Nature, vol.46, issue.7344, pp.495-498, 2011.
DOI : 10.1038/nature09914

D. Goldstein, Common genetic variation and human traits. The New England journal of 24 medicine, pp.1696-1698, 2009.
DOI : 10.1056/nejmp0806284

M. Martin, Epistatic interaction between KIR3DS1 and HLA?B delays the progression to 26 AIDS, Nature genetics, vol.31, issue.27, pp.429-434, 2002.

P. Kamya, Receptor?ligand requirements for increased NK cell polyfunctional potential in 28 slow progressors infected with HIV?1 coexpressing KIR3DL1*h/*y and HLA?B*57, p.29

M. Martin, Innate partnership of HLA?B and KIR3DL1 subtypes against HIV?1. Nature 31 genetics, pp.733-740, 2007.

C. Tomescu, Impact of protective killer inhibitory receptor/human leukocyte antigen genotypes on natural killer cell and T-cell function in HIV-1-infected controllers, AIDS, vol.26, issue.15, pp.1869-1903, 2012.
DOI : 10.1097/QAD.0b013e32835861b0

O. Connell, K. Han, Y. Williams, T. Siliciano, R. Blankson et al., Role of natural killer cells in a 36 cohort of elite suppressors: low frequency of the protective KIR3DS1 allele and limited inhibition of 37 human immunodeficiency virus type 1 replication in vitro Sáez?Cirión A, et al. HIV controllers exhibit potent CD8 T cell capacity to suppress HIV 39 infection ex vivo and peculiar CTL activation phenotype, 5028?5034. 38 68, pp.6776-6816, 2007.

C. Day, PD-1 expression on HIV-specific T cells is associated with T-cell exhaustion and disease progression, Nature, vol.170, issue.7109, pp.350-354, 2006.
DOI : 10.1126/science.274.5284.94

C. Petrovas, Differential Association of Programmed Death-1 and CD57 with Ex Vivo Survival of CD8+ T Cells in HIV Infection, The Journal of Immunology, vol.183, issue.2, pp.1120-1132, 2009.
DOI : 10.4049/jimmunol.0900182

J. Giorgi, Shorter Survival in Advanced Human Immunodeficiency Virus Type 1 Infection Is More Closely Associated with T Lymphocyte Activation than with Plasma Virus Burden or Virus Chemokine Coreceptor Usage, The Journal of Infectious Diseases, vol.179, issue.4, pp.859-870, 1999.
DOI : 10.1086/314660

H. Horton, Preservation of T Cell Proliferation Restricted by Protective HLA Alleles Is Critical for Immune Control of HIV-1 Infection, The Journal of Immunology, vol.177, issue.10, pp.7406-7415, 2006.
DOI : 10.4049/jimmunol.177.10.7406

M. Betts, HIV nonprogressors preferentially maintain highly functional HIV-specific CD8+ T cells, Blood, vol.107, issue.12, pp.4781-4789, 2006.
DOI : 10.1182/blood-2005-12-4818
URL : http://www.ncbi.nlm.nih.gov/pmc/articles/PMC1895811

H. Streeck, Antigen Load and Viral Sequence Diversification Determine the Functional Profile of HIV-1???Specific CD8+ T Cells, PLoS Medicine, vol.302, issue.5, pp.100-102, 2008.
DOI : 10.1371/journal.pmed.0050100.st001

S. Migueles, HIV-specific CD8+ T cell proliferation is coupled to perforin expression and is maintained in nonprogressors, Nature Immunology, vol.3, issue.11, pp.1061-1068, 2002.
DOI : 10.1038/ni845

S. Migueles, Lytic Granule Loading of CD8+ T Cells Is Required for HIV-Infected Cell Elimination Associated with Immune Control, Immunity, vol.29, issue.6, pp.1009-1021, 2008.
DOI : 10.1016/j.immuni.2008.10.010

A. Hersperger, Perforin Expression Directly Ex Vivo by HIV-Specific CD8+ T-Cells Is a Correlate of HIV Elite Control, PLoS Pathogens, vol.16, issue.5, pp.1000917-78, 2010.
DOI : 10.1371/journal.ppat.1000917.s014

M. Addo, Fully Differentiated HIV-1 Specific CD8+ T Effector Cells Are More Frequently Detectable in Controlled than in Progressive HIV-1 Infection, PLoS ONE, vol.77, issue.3, pp.321-79, 2007.
DOI : 10.1371/journal.pone.0000321.t001

H. Chen, Differential Neutralization of Human Immunodeficiency Virus (HIV) Replication in Autologous CD4 T Cells by HIV-Specific Cytotoxic T Lymphocytes, Journal of Virology, vol.83, issue.7, pp.3138-3149, 2009.
DOI : 10.1128/JVI.02073-08

P. Kiepiela, CD8+ T-cell responses to different HIV proteins have discordant associations with viral load, Nature Medicine, vol.53, issue.1, pp.46-53, 2007.
DOI : 10.1038/nm1520

O. Pontesilli, Longitudinal Analysis of Human Immunodeficiency Virus Type 1???Specific Cytotoxic T Lymphocyte Responses: A Predominant Gag???Specific Response Is Associated with Nonprogressive Infection, The Journal of Infectious Diseases, vol.178, issue.4, pp.1008-1018, 1998.
DOI : 10.1086/515659

B. Edwards, A. Bansal, S. Sabbaj, J. Bakari, M. Mulligan et al., Magnitude of Functional CD8+ T-Cell Responses to the Gag Protein of Human Immunodeficiency Virus Type 1 Correlates Inversely with Viral Load in Plasma, Journal of Virology, vol.76, issue.5, pp.2298-2305, 2002.
DOI : 10.1128/jvi.76.5.2298-2305.2002

B. Descours, Immune responses driven by protective human leukocyte antigen alleles 21 from long?term nonprogressors are associated with low HIV reservoir in central memory CD4 T cells, Clin Infect Dis, vol.2254, issue.23, pp.1495-1503, 2012.

A. Ferre, Mucosal immune responses to HIV-1 in elite controllers: a potential correlate of immune control, Blood, vol.113, issue.17, pp.3978-3989, 2009.
DOI : 10.1182/blood-2008-10-182709

A. Ferre, Immunodominant HIV-Specific CD8+ T-Cell Responses Are Common to Blood and Gastrointestinal Mucosa, and Gag-Specific Responses Dominate in Rectal Mucosa of HIV Controllers, Journal of Virology, vol.84, issue.19, pp.10354-10365, 2010.
DOI : 10.1128/JVI.00803-10

T. Miura, HLA-Associated Viral Mutations Are Common in Human Immunodeficiency Virus Type 1 Elite Controllers, Journal of Virology, vol.83, issue.7, pp.3407-3412, 2009.
DOI : 10.1128/JVI.02459-08

Y. Wang, Protective HLA Class I Alleles That Restrict Acute-Phase CD8+ T-Cell Responses Are Associated with Viral Escape Mutations Located in Highly Conserved Regions of Human Immunodeficiency Virus Type 1, Journal of Virology, vol.83, issue.4, pp.1845-1855, 2009.
DOI : 10.1128/JVI.01061-08

B. Mothe, CTL Responses of High Functional Avidity and Broad Variant Cross-Reactivity Are Associated with HIV Control, PLoS ONE, vol.118, issue.1, pp.29717-90, 2012.
DOI : 10.1371/journal.pone.0029717.s003

J. Almeida, Antigen sensitivity is a major determinant of CD8+ T-cell polyfunctionality and HIV-suppressive activity, Blood, vol.113, issue.25, pp.6351-6360, 2009.
DOI : 10.1182/blood-2009-02-206557
URL : https://hal.archives-ouvertes.fr/inserm-00668485

H. Chen, TCR clonotypes modulate the protective effect of HLA class I molecules in HIV-1 infection, Nature Immunology, vol.172, issue.7, pp.691-700, 2012.
DOI : 10.1038/ni.2342

K. Ladell, A molecular basis for the control of pre?immune escape variants by HIV? 42 specific CD8+ T?cells, Immunity, vol.43, p.93, 2013.

J. Huang, Leukocyte immunoglobulin?like receptors maintain unique antigen?presenting 44 properties of circulating myeloid dendritic cells in HIV?1?infected elite controllers, p.45

C. Lecuroux, CD8 T?cells from most HIV?infected patients lack HIV?suppressive capacity 47 during acute and early infection, PLoS One, vol.48, p.95, 2013.

B. Emu, HLA Class I-Restricted T-Cell Responses May Contribute to the Control of Human Immunodeficiency Virus Infection, but Such Responses Are Not Always Necessary for Long-Term Virus Control, Journal of Virology, vol.82, issue.11, pp.5398-5407, 2008.
DOI : 10.1128/JVI.02176-07

R. Buckheit, M. Salgado, R. Silciano, and J. Blankson, Inhibitory Potential of Subpopulations of CD8+ T Cells in HIV-1-Infected Elite Suppressors, Journal of Virology, vol.86, issue.24, p.97, 2012.
DOI : 10.1128/JVI.02439-12

Z. Ndhlovu, Elite Controllers with Low to Absent Effector CD8+ T Cell Responses Maintain Highly Functional, Broadly Directed Central Memory Responses, Journal of Virology, vol.86, issue.12, pp.6959-6969, 2012.
DOI : 10.1128/JVI.00531-12
URL : http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3393560

L. Shan, Stimulation of HIV-1-Specific Cytolytic T Lymphocytes Facilitates Elimination of Latent Viral Reservoir after Virus Reactivation, Immunity, vol.36, issue.3, pp.491-501, 2012.
DOI : 10.1016/j.immuni.2012.01.014

J. Schulze-zur-wiesch, Comprehensive Analysis of Frequency and Phenotype of T Regulatory Cells in HIV Infection: CD39 Expression of FoxP3+ T Regulatory Cells Correlates with Progressive Disease, Journal of Virology, vol.85, issue.3, pp.1287-1297, 2011.
DOI : 10.1128/JVI.01758-10

M. Angin, Preserved Function of Regulatory T Cells in Chronic HIV-1 Infection Despite Decreased Numbers in Blood and Tissue, Journal of Infectious Diseases, vol.205, issue.10, pp.1495-1500, 2012.
DOI : 10.1093/infdis/jis236

J. Shaw, Increased Frequency of Regulatory T Cells Accompanies Increased Immune Activation in Rectal Mucosae of HIV-Positive Noncontrollers, Journal of Virology, vol.85, issue.21, pp.11422-11434, 2011.
DOI : 10.1128/JVI.05608-11

P. Hunt, A Low T Regulatory Cell Response May Contribute to Both Viral Control and Generalized Immune Activation in HIV Controllers, PLoS ONE, vol.280, issue.1, pp.15924-15939, 2011.
DOI : 10.1371/journal.pone.0015924.s001

O. Lambotte, Heterogeneous neutralizing antibody and antibody-dependent cell cytotoxicity responses in HIV-1 elite controllers, AIDS, vol.23, issue.8, pp.897-906, 2009.
DOI : 10.1097/QAD.0b013e328329f97d
URL : https://hal.archives-ouvertes.fr/inserm-00387059

Q. Liu, Matrix Metalloprotease Inhibitors Restore Impaired NK Cell-Mediated Antibody-Dependent Cellular Cytotoxicity in Human Immunodeficiency Virus Type 1 Infection, Journal of Virology, vol.83, issue.17, pp.8705-8712, 2009.
DOI : 10.1128/JVI.02666-08

D. Mendoza, Comprehensive analysis of unique cases with extraordinary control over HIV replication, Blood, vol.119, issue.20, pp.4645-4655, 2012.
DOI : 10.1182/blood-2011-10-381996

M. Rotger, Genome-Wide mRNA Expression Correlates of Viral Control in CD4+ T-Cells from HIV-1-Infected Individuals, PLoS Pathogens, vol.4, issue.2, pp.1000781-1000808, 2010.
DOI : 10.1371/journal.ppat.1000781.s015

R. Owen, HIV+ elite controllers have low HIV-specific T-cell activation yet maintain strong, polyfunctional T-cell responses, AIDS, vol.24, issue.8, pp.1095-1105, 2010.
DOI : 10.1097/QAD.0b013e3283377a1e
URL : http://www.ncbi.nlm.nih.gov/pmc/articles/PMC2972651

B. Vingert, HIV Controllers Maintain a Population of Highly Efficient Th1 Effector Cells in Contrast to Patients Treated in the Long Term, Journal of Virology, vol.86, issue.19, pp.10661-10674, 2012.
DOI : 10.1128/JVI.00056-12
URL : https://hal.archives-ouvertes.fr/pasteur-00733917

D. Kaufmann, Upregulation of CTLA-4 by HIV-specific CD4+ T cells correlates with disease progression and defines a reversible immune dysfunction, Nature Immunology, vol.170, issue.11, pp.1246-1254, 2007.
DOI : 10.1038/ni1515

B. Emu, Phenotypic, functional, and kinetic parameters associated with apparent T?cell 34 control of human immunodeficiency virus replication in individuals with and without antiretroviral 35 treatment, 14169?14178. 36 112. van Grevenynghe J, et al. Transcription factor FOXO3a controls the persistence of memory 37 CD4(+) T cells during HIV infection, pp.266-274, 2005.

B. Vingert, HIV Controller CD4+ T Cells Respond to Minimal Amounts of Gag Antigen Due to High TCR Avidity, PLoS Pathogens, vol.77, issue.2, pp.1000780-1000820, 2010.
DOI : 10.1371/journal.ppat.1000780.s007

A. Ferre, HIV Controllers with HLA-DRB1*13 and HLA-DQB1*06 Alleles Have Strong, Polyfunctional Mucosal CD4+ T-Cell Responses, Journal of Virology, vol.84, issue.21, pp.11020-11029, 2010.
DOI : 10.1128/JVI.00980-10
URL : http://www.ncbi.nlm.nih.gov/pmc/articles/PMC2953185

N. Chomont, HIV reservoir size and persistence are driven by T cell survival and homeostatic proliferation, Nature Medicine, vol.45, issue.8, pp.893-900, 2009.
DOI : 10.1038/nm.1972
URL : http://www.ncbi.nlm.nih.gov/pmc/articles/PMC2859814

H. Chen, CD4+ T cells from elite controllers resist HIV-1 infection by selective upregulation of p21, Journal of Clinical Investigation, vol.121, issue.4, pp.1549-1560, 2011.
DOI : 10.1172/JCI44539DS1

A. Saez?cirion, Restriction of HIV-1 replication in macrophages and CD4+ T cells from HIV controllers, Blood, vol.118, issue.4, pp.955-964, 2011.
DOI : 10.1182/blood-2010-12-327106
URL : https://hal.archives-ouvertes.fr/pasteur-01420583

M. Buzon, Inhibition of HIV-1 Integration in Ex Vivo-Infected CD4 T Cells from Elite Controllers, Journal of Virology, vol.85, issue.18, pp.9646-9650, 2011.
DOI : 10.1128/JVI.05327-11

J. Zhang, D. Scadden, and C. Crumpacker, Primitive hematopoietic cells resist HIV-1 infection via p21Waf1/Cip1/Sdi1, Journal of Clinical Investigation, vol.117, issue.2, pp.473-481, 2007.
DOI : 10.1172/JCI28971DS1
URL : http://www.ncbi.nlm.nih.gov/pmc/articles/PMC1783820

A. Bergamaschi, A. David, L. Rouzic, E. Nisole, S. Barre?sinoussi et al., The CDK inhibitor 1 p21Cip1/WAF1 is induced by FcgammaR activation and restricts the replication of human 2 immunodeficiency virus type 1 and related primate lentiviruses in human macrophages

O. Connell, K. Rabi, S. Siliciano, R. Blankson, and J. , CD4+ T cells from elite suppressors are more susceptible to HIV-1 but produce fewer virions than cells from chronic progressors, Proceedings of the National Academy of Sciences, vol.184, issue.3, pp.689-698, 2011.
DOI : 10.1128/JVI.78.4.1718-1729.2004

J. Palacios, Long?term nonprogressor and elite controller patients who control viremia 8 have a higher percentage of methylation in their HIV?1 proviral promoters than aviremic patients 9 receiving highly active antiretroviral therapy Deeks SG, et al. Towards an HIV cure: a global scientific strategy, J Virol, vol.8612, pp.607-614, 2012.

C. Goujard, HIV-1 control after transient antiretroviral treatment initiated in primary infection: role of patient characteristics and effect of therapy, Antiviral Therapy, vol.17, issue.6, pp.1001-1009, 2012.
DOI : 10.3851/IMP2273

L. Hocqueloux, Long-term immunovirologic control following antiretroviral therapy interruption in patients treated at the time of primary HIV-1 infection, AIDS, vol.24, issue.10, pp.1598-1601, 2010.
DOI : 10.1097/QAD.0b013e32833b61ba

S. Lodi, Immunovirologic Control 24 Months After Interruption of Antiretroviral Therapy Initiated Close to HIV Seroconversion, Archives of Internal Medicine, vol.172, issue.16, pp.1252-1255, 2012.
DOI : 10.1001/archinternmed.2012.2719

A. Saez?cirion, Post?treatment HIV?1 controllers with a long?term virological remission 19 after the interruption of early initiated antiretroviral therapy. ANRS VISCONTI study, 1921.

E. Van-gulck, Immune and viral correlates of "secondary viral control" after treatment 22 interruption in chronically HIV?1 infected patients Ngo?Giang?Huong N, et al. Proviral HIV?1 DNA in subjects followed since primary HIV?1 24 infection who suppress plasma viral load after one year of highly active antiretroviral therapy, PLoS ONE. AIDS, vol.715, pp.37792-37815, 2001.

E. Delwart, Homogeneous quasispecies in 16 out of 17 individuals during very early HIV-1 primary infection, AIDS, vol.16, issue.2, pp.189-195, 2002.
DOI : 10.1097/00002030-200201250-00007

G. Alter, Sequential deregulation of NK cell subset distribution and function starting in acute HIV-1 infection, Blood, vol.106, issue.10, pp.3366-3369, 2005.
DOI : 10.1182/blood-2005-03-1100

S. Moir, B cells in early and chronic HIV infection: evidence for preservation of immune function associated with early initiation of antiretroviral therapy, Blood, vol.116, issue.25, pp.5571-5579, 2010.
DOI : 10.1182/blood-2010-05-285528

A. Oxenius, Early highly active antiretroviral therapy for acute HIV-1 infection preserves immune function of CD8+ and CD4+ T lymphocytes, Proceedings of the National Academy of Sciences, vol.5, issue.5, pp.3382-3387, 2000.
DOI : 10.1038/8400

C. Petrovas, CD4 T follicular helper cell dynamics during SIV infection, Journal of Clinical Investigation, vol.122, issue.9, pp.3281-3294, 2012.
DOI : 10.1172/JCI63039DS1
URL : http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3428091

M. Lindqvist, Expansion of HIV-specific T follicular helper cells in chronic HIV infection, Journal of Clinical Investigation, vol.122, issue.9, pp.3271-3280, 2012.
DOI : 10.1172/JCI64314DS1

J. Hong, P. Amancha, K. Rogers, A. Ansari, and F. Villinger, Spatial Alterations between CD4+ T Follicular Helper, B, and CD8+ T Cells during Simian Immunodeficiency Virus Infection: T/B Cell Homeostasis, Activation, and Potential Mechanism for Viral Escape, The Journal of Immunology, vol.188, issue.7, pp.3247-3256, 2012.
DOI : 10.4049/jimmunol.1103138

M. Perreau, Follicular helper T cells serve as the major CD4 T cell compartment for HIV-1 infection, replication, and production, The Journal of Experimental Medicine, vol.9, issue.1, pp.143-156, 2012.
DOI : 10.1126/science.278.5341.1291

G. Pancino, G. Silvestri, and K. Fowke, Models of Protection Against HIV/SIV. Avoiding AIDS in 44 humans and monkeys, p.45, 2012.

P. Mudd, Vaccine-induced CD8+ T cells control AIDS virus replication, Nature, vol.4, issue.7422, pp.129-133, 2012.
DOI : 10.1038/nature11443
URL : http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3883109

S. Hansen, Profound early control of highly pathogenic SIV by an effector memory T-cell vaccine, Nature, vol.81, issue.7348, pp.523-527, 2011.
DOI : 10.1038/nature10003